Microbiome Sequencing Market to Hit $3.4 Billion by 2031 at 14.8% CAGR
The global microbiome sequencing market is entering a rapid growth phase, fueled by breakthroughs in genomics, rising demand for personalized medicine, and increasing investments in microbiome research. Valued at $859.4 million in 2021, the market is projected to reach $3,417.09 million by 2031, growing at a CAGR of 14.8% from 2022 to 2031. This surge reflects the expanding role of microbiome sequencing in understanding disease mechanisms and advancing precision healthcare solutions. Market Statistics - Market Size (2021): $859.4 million Forecast Value (2031): $3,417.09 million CAGR (2022–2031): 14.8% Key Growth Drivers: Rising microbiome research, personalized medicine demand, next-generation sequencing adoption The growing importance of microbial communities in human health is one of the key factors driving the microbiome sequencing market. Microbiome sequencing enables researchers to analyze the genetic material of microorganisms such as bacteria, viruses, fungi, and parasites,...